台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    102.5
  • 漲跌
    ▼0.5
  • 漲幅
    -0.49%
  • 成交量
    55
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智基 (6294)籌碼相關-新加坡商瑞銀 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

新加坡商瑞銀 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/2200.004103.50103.00-4157-2.54%
2024/05/212102.0000.00102.0021551.28%
2024/05/2000.004103.50103.50-4154-2.59%
2024/05/172106.5012105.67105.50-10152-6.57%
2024/05/167106.5000.00107.0071504.66%
2024/05/1530102.1715103.57104.001514810.11%
2024/05/147399.384099.91102.003314422.81%
2024/05/104118.5000.00118.5041203.33%
2024/05/099118.8300.00118.5091197.51%
2024/05/073119.5000.00119.5031192.52%
2024/05/0600.002118.00119.00-2118-1.69%
2024/05/0200.001117.50118.00-1116-0.86%
2024/04/3000.001117.50118.00-1116-0.86%
2024/04/2900.004118.00117.50-4116-3.43%
2024/04/221116.0000.00116.0011140.88%
2024/04/1600.003114.50114.00-3111-2.70%
2024/04/1500.002116.50117.00-2107-1.86%
2024/04/1100.001119.50119.50-1101-0.98%
2024/04/1000.001126.50127.00-195-1.04%
2024/04/022123.0000.00123.502702.83%
2024/04/013122.5000.00123.003694.31%
2024/03/2700.006121.50122.00-666-9.07%
2024/03/2600.003122.83123.00-363-4.70%
2024/03/251124.001123.00124.000620.00%
2024/03/211121.5000.00121.501581.71%
2024/03/1900.002123.00123.00-255-3.63%
2024/03/1800.002123.00124.00-251-3.91%
2024/03/152120.5000.00121.502474.25%
2024/03/122116.7500.00117.002385.15%
2024/03/043113.0000.00112.503339.08%
2023/09/212114.5000.00114.002267.48%
2023/08/171110.5000.00110.501313.17%
2023/07/311111.5000.00111.501333.01%
2023/07/101108.5000.00108.501392.51%
2023/06/1500.001109.00109.00-155-1.81%
2023/06/1400.002108.00107.50-254-3.66%
2023/05/2900.002109.00109.00-256-3.56%
2023/05/2400.003109.00109.00-356-5.33%
2023/05/2300.002109.00109.00-256-3.55%
2023/05/222109.003109.17109.00-156-1.78%
2023/05/192108.5000.00108.502553.57%
2023/05/181108.0000.00108.501551.79%
2023/05/1700.001108.00108.00-155-1.79%
2023/05/152107.002107.50107.500550.00%
2023/05/1200.001106.50106.50-155-1.80%
2023/05/0900.0010107.10107.00-1055-18.09%
2023/05/0300.003108.50108.50-352-5.69%
2023/05/0200.001109.00109.00-152-1.90%
2023/04/2600.003108.00108.50-353-5.66%
2023/04/2100.001108.00108.00-153-1.88%
2023/04/171111.5000.00109.501511.95%
2023/04/1000.001120.00120.50-139-2.56%
2023/03/271118.0000.00117.501332.96%
2021/06/1000.007149.65151.50-746-14.95%
2021/06/0900.002147.00147.00-244-4.46%
2020/09/0300.0012111.38111.00-1256-21.27%
2020/09/0200.002112.00112.50-256-3.53%
2020/03/1300.004393.5395.10-4333-129.71%
2020/03/1200.002398.5098.10-2330-76.54%
2020/03/1100.003100.17100.00-328-10.58%
2019/07/2600.000.2102.50102.00-0.246-0.43%
2018/11/2600.002103.25104.00-229-6.89%
2018/11/2300.001103.00104.50-129-3.44%
2018/11/2200.001105.50105.50-129-3.45%
2018/11/1900.001103.50103.50-129-3.44%
2018/11/0900.006103.58104.50-629-20.43%
2018/11/0800.003106.17105.50-328-10.45%
2018/11/0700.003105.67106.00-328-10.49%
2018/09/2000.002105.75105.00-250-3.93%
2018/09/1900.002105.50106.50-250-3.93%
2018/09/1800.001105.50106.00-151-1.94%
2018/09/1700.001105.50106.50-152-1.91%
2018/09/1400.002106.75107.00-252-3.81%
2018/09/1300.002106.00106.00-252-3.79%
2018/09/1200.002105.00105.50-252-3.78%
2018/09/1100.003104.50105.00-353-5.64%
2018/09/1000.002104.75104.50-253-3.75%
2018/09/0700.003106.67106.00-352-5.67%
2018/09/0600.001108.00108.50-151-1.93%
2018/09/0500.001108.50108.50-152-1.92%
2018/09/0400.002109.00109.50-252-3.81%
2018/09/0300.001109.00109.50-153-1.88%
2018/08/3100.003110.50110.00-353-5.66%
2018/08/3000.001110.50111.00-154-1.85%
2018/08/2900.001110.50111.50-155-1.81%
2018/08/2700.001110.00111.00-156-1.76%
2018/08/2300.001110.50110.50-157-1.74%
2018/08/2000.001109.50109.50-159-1.69%
2018/08/1700.002109.75109.50-260-3.29%
2018/08/1600.004109.13109.00-461-6.55%
2018/08/1500.002109.50109.50-261-3.26%
2018/08/1300.005108.80108.00-562-7.98%
2018/08/0900.003111.50111.00-361-4.88%
2018/07/2600.003108.33108.00-387-3.41%
2018/07/2300.002126.00126.50-285-2.34%
2018/07/1900.002125.50125.50-283-2.40%
2018/07/1300.001125.00124.50-182-1.22%
2018/07/0600.001125.00125.00-186-1.16%
2018/06/0100.001124.00124.00-1121-0.82%
2018/05/2500.001124.50123.00-1124-0.80%
2018/05/083131.0000.00130.5031262.38%
2018/05/0712131.9600.00131.50121249.63%
2018/05/042128.0000.00128.5021171.70%
2018/05/033129.0000.00129.0031162.58%
2018/04/271125.5000.00124.0011170.85%
2018/04/232124.0000.00124.0021491.34%
2018/04/091127.0000.00127.0011640.61%
2018/04/024130.6300.00129.5041622.47%
2018/03/231124.0000.00124.0011660.60%
2018/03/223127.5000.00125.5031701.76%
2018/03/211128.5000.00128.5011830.54%
2018/03/195128.0000.00127.5051762.83%
2018/03/151122.0000.00122.5011680.59%
2018/03/121120.0000.00120.0011710.58%
2018/03/052120.5000.00120.0021761.13%
2018/03/023120.6700.00120.0031751.71%
2018/03/012118.2500.00118.0021721.16%
2018/02/262118.0000.00116.5021721.16%
2018/02/231118.5000.00117.0011690.59%
2018/02/121114.0000.00113.5011670.60%
2018/02/082116.0000.00116.0021651.21%
2018/02/064112.632117.00112.0021651.21%
2018/02/051122.0000.00122.0011630.61%
2018/02/023122.1700.00123.0031631.83%
2018/02/011119.0000.00120.0011630.61%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音